2022
Characteristics Associated with Spirometry Guideline Adherence in VA Patients Hospitalized with Chronic Obstructive Pulmonary Disease
Rodwin BA, DeRycke EC, Han L, Bade BC, Brandt CA, Bastian LA, Akgün KM. Characteristics Associated with Spirometry Guideline Adherence in VA Patients Hospitalized with Chronic Obstructive Pulmonary Disease. Journal Of General Internal Medicine 2022, 38: 619-626. PMID: 36241942, PMCID: PMC9971396, DOI: 10.1007/s11606-022-07826-5.Peer-Reviewed Original ResearchMeSH KeywordsAsthmaGuideline AdherenceHumansPulmonary Disease, Chronic ObstructiveRetrospective StudiesSpirometryConceptsChronic obstructive pulmonary diseaseHigh-risk COPD patientsObstructive pulmonary diseaseAnnual spirometryCOPD patientsClinic visitsPulmonary diseaseChronic obstructive lung diseaseVeterans Health Administration facilitiesPost-hospitalization careGuideline-concordant careObstructive lung diseaseYear of hospitalizationCorporate Data WarehouseProvider-level dataPulmonary clinicGuideline adherencePatient demographicsConcordant careCOPD hospitalizationsPrimary outcomeVA patientsLung diseaseProvider variablesProvider age
2014
Effect of &bgr;-Blockers on Cardiac and Pulmonary Events and Death in Older Adults With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease
Lee DS, Markwardt S, McAvay GJ, Gross CP, Goeres LM, Han L, Peduzzi P, Lin H, Dodson JA, Tinetti ME. Effect of &bgr;-Blockers on Cardiac and Pulmonary Events and Death in Older Adults With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease. Medical Care 2014, 52: s45-s51. PMID: 24561758, PMCID: PMC4050644, DOI: 10.1097/mlr.0000000000000035.Peer-Reviewed Original ResearchConceptsChronic obstructive pulmonary diseaseΒ-blocker useMajor cardiac eventsObstructive pulmonary diseasePulmonary eventsCardiovascular diseaseCardiac eventsOlder adultsPulmonary diseaseΒ-blockersCOPD/asthmaMajor pulmonary eventsCox proportional hazardsPulmonary outcomesCause mortalityHazard ratioStudy criteriaMedicare beneficiariesProportional hazardsSurvey cohortDiseaseAdultsMedicationsOutcomesDeath